The global image-guided therapy systems market size is expected to reach USD 6.9 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to reach at a CAGR of 5.2% from 2023 to 2030. Growing geriatric population and increasing cases of chronic diseases are expected to boost the market demand. Other factors propelling the industry growth include rising preference for minimally invasive surgeries and technological advancements in image-guided therapy systems. Various initiatives undertaken in the area of cancer radiotherapy are driving the industry.
New product launches by major companies are also having a positive impact on market growth. For instance, in September 2020, Olympus Corporation launched ENDO-AID, an AI platform and endoscopy application with computer-aided detection for gastrointestinal applications. The AI platform with an endoscopy system-EVIS X1 enables real-time display. The growing adoption of such advanced systems is expected to drive the industry. The increasing number of initiatives undertaken by public and private firms in the area of cancer radiotherapy is also estimated to have a positive impact on industry growth.
Additionally, many academic institutions are investing in cancer radiotherapy projects for increasing the effectiveness of treatment therapies. This is also likely to contribute to market expansion. The development of the Image-guided Therapy Program by the Brigham and Women’s Hospital aimed at advancing imaging and therapeutic technologies for developing minimally invasive surgical and interventional techniques is an example of one such initiative.
Request a free sample copy or view report summary: Image-guided Therapy Systems Market Report
North America accounted for the largest revenue share in 2022 owing to the rising geriatric population and high per capita expenditure
Based on product, the endoscopes segment accounted for the largest revenue share in 2022 owing to technological advancements, high volume of endoscope-guided surgeries, and rising preference for minimally invasive surgeries
On the basis of application, cardiac surgery emerged as the largest application segment in 2022 owing to factors such as rising prevalence of target diseases, preference for minimally invasive cardiac surgeries, and R&D initiatives aimed at developing real-time cardiac intervention systems
By end-use, the hospitals segment accounted for the largest revenue share in 2022 as the hospital settings are equipped with technologically advanced devices
The ambulatory surgery centers segment is projected to expand at the fastest CAGR of 5.9% over the forecast period
Grand View Research has segmented the global image-guided therapy systems market based on product, application, end-use, and region:
Image-guided Therapy Systems Product Outlook (Revenue, USD Million, 2018 - 2030)
Computed Tomography (CT) Scanners
Ultrasound Systems
Magnetic Resonance Imaging (MRI)
Endoscopes
X-ray Fluoroscopy
Positron Emission Tomography (PET)
Single Photon Emission Computed Tomography (SPECT)
Image-guided Therapy Systems Application Outlook (Revenue, USD Million, 2018 - 2030)
Cardiac Surgery
Neurosurgery
Orthopedic Surgery
Urology
Oncology Surgery
Gastroenterology
Others
Image-guided Therapy Systems End-use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Research & Academic Institutions
Image-guided Therapy Systems Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Sweden
Denmark
Norway
Asia Pacific
Japan
China
India
South Korea
Australia
Thailand
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players of Image-guided Therapy Systems Market
Koninklijke Philips N.V.
Medtronic
Siemens Healthineers
Analogic Corporation
GE Healthcare
Varian Medical Systems, Inc.
Brainlab AG
Olympus Corporation
Stryker
"The quality of research they have done for us has been excellent..."